DK0488513T3 - Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen - Google Patents

Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen

Info

Publication number: DK0488513T3
Authority: DK; Denmark
Prior art keywords: dioxabicyclo; drug; prepare; cholesterol metabolism; inhibiting cholesterol
Prior art date: 1990-10-22

Application number

DK91309685.5T

Other languages

Danish (da)

English (en)

Inventor

Kengo Akimoto

Sumio Asami

Michihiro Sugano

Nobuaki Hirose

Original Assignee

Suntory Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-10-22

Filing date

1991-10-21

Publication date

1996-06-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17644733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0488513(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-10-21 Application filed by Suntory Ltd filed Critical Suntory Ltd

1996-06-17 Application granted granted Critical

1996-06-17 Publication of DK0488513T3 publication Critical patent/DK0488513T3/da

Links

HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract 4
XNWFXTOHNKPYMK-UHFFFAOYSA-N 3,3a,4,5,6,6a-hexahydrocyclopenta[c]dioxole Chemical class C1OOC2CCCC21 XNWFXTOHNKPYMK-UHFFFAOYSA-N 0.000 title abstract 2
230000002401 inhibitory effect Effects 0.000 title abstract 2
230000004060 metabolic process Effects 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
235000012000 cholesterol Nutrition 0.000 abstract 1
125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Steroid Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK91309685.5T 1990-10-22 1991-10-21 Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen DK0488513T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP28183990A JP3183664B2 (ja)	1990-10-22	1990-10-22	コレステロール及び胆汁酸の代謝阻害剤

Publications (1)

Publication Number	Publication Date
DK0488513T3 true DK0488513T3 (da)	1996-06-17

Family

ID=17644733

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91309685.5T DK0488513T3 (da)	1990-10-22	1991-10-21	Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen

Country Status (9)

Country	Link
US (1)	US5270335A (fr)
EP (1)	EP0488513B1 (fr)
JP (1)	JP3183664B2 (fr)
AT (1)	ATE138571T1 (fr)
CA (1)	CA2053820C (fr)
DE (1)	DE69119875T2 (fr)
DK (1)	DK0488513T3 (fr)
ES (1)	ES2087252T3 (fr)
GR (1)	GR3020682T3 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3283274B2 (ja) *	1991-06-15	2002-05-20	サントリー株式会社	新規組成物
JPH06227977A (ja) *	1993-02-01	1994-08-16	Suntory Ltd	活性酸素消去剤
AU1928295A (en) *	1994-02-25	1995-09-11	New England Deaconess Hospital Corporation	Anti-inflammatory and infection protective effects of sesamin-based lignans
US5397778A (en) *	1994-02-25	1995-03-14	New England Deaconess Hospital Corporation	Enteral formulations for treatment of inflammation and infection
JP3818680B2 (ja) *	1994-05-12	2006-09-06	サントリー株式会社	アレルギー症状の予防又は改善剤
AU716372C (en) *	1995-07-04	2001-07-26	Suntory Holdings Limited	Food composition containing an omega-6/omega-3 unsaturated fatty acid balance modifier
JPH11246427A (ja) *	1998-03-04	1999-09-14	Kadoya Sesami Mills Inc	糖・脂質代謝活性化剤
KR100352269B1 (ko) *	1999-10-08	2002-09-12	한국생명공학연구원	저밀도 지질 단백질에 대해 항산화 활성을 갖는 리그난계 화합물
JP4388248B2 (ja) *	2001-10-29	2009-12-24	株式会社日立製作所	最適ポートフォリオ決定方法および装置
US7081260B2 (en) *	2002-10-29	2006-07-25	Council Of Scientific And Industrial Research	α-Glucosidase inhibitors from a natural source
US8685455B2 (en) *	2005-03-31	2014-04-01	Suntory Holdings Limited	Oil-in-water emulsions containing lignan-class compounds and compositions containing the same
JP5091680B2 (ja)	2005-09-30	2012-12-05	サントリーホールディングス株式会社	エピセサミン高含有組成物の製造方法及び装置
SG172594A1 (en)	2006-03-31	2011-07-28	Suntory Holdings Ltd Jp	Compositions containing lignan-class compounds
CN101511356A (zh)	2006-10-04	2009-08-19	三得利株式会社	含有木脂素类化合物的o/w/o型乳液及含有该乳液的组合物
JP5051878B2 (ja) *	2007-03-02	2012-10-17	竹本油脂株式会社	高濃度セサミノール含有物の製造方法
US8703789B2 (en)	2007-09-19	2014-04-22	Suntory Holdings Limited	Compositions incorporating sesamin-class compounds and vitamin B1 class compounds
JP7366991B2 (ja) *	2019-02-28	2023-10-23	株式会社えがお	体重増加抑制・低減用組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2021714C (fr) *	1989-07-21	1996-07-23	Yoshifumi Shinmen	Ameliorateur de la fonction hepatique

1990
- 1990-10-22 JP JP28183990A patent/JP3183664B2/ja not_active Expired - Lifetime
1991
- 1991-10-21 EP EP91309685A patent/EP0488513B1/fr not_active Expired - Lifetime
- 1991-10-21 CA CA002053820A patent/CA2053820C/fr not_active Expired - Lifetime
- 1991-10-21 DK DK91309685.5T patent/DK0488513T3/da active
- 1991-10-21 AT AT91309685T patent/ATE138571T1/de not_active IP Right Cessation
- 1991-10-21 US US07/779,998 patent/US5270335A/en not_active Expired - Lifetime
- 1991-10-21 ES ES91309685T patent/ES2087252T3/es not_active Expired - Lifetime
- 1991-10-21 DE DE69119875T patent/DE69119875T2/de not_active Expired - Lifetime
1996
- 1996-07-31 GR GR960402040T patent/GR3020682T3/el unknown

Also Published As

Publication number	Publication date
DE69119875D1 (de)	1996-07-04
ATE138571T1 (de)	1996-06-15
EP0488513A3 (fr)	1992-06-17
EP0488513A2 (fr)	1992-06-03
CA2053820C (fr)	1997-02-04
CA2053820A1 (fr)	1992-04-23
JP3183664B2 (ja)	2001-07-09
GR3020682T3 (en)	1996-10-31
DE69119875T2 (de)	1996-10-02
EP0488513B1 (fr)	1996-05-29
ES2087252T3 (es)	1996-07-16
US5270335A (en)	1993-12-14
JPH04159221A (ja)	1992-06-02

Similar Documents

Publication	Publication Date	Title
DK0488513T3 (da)	1996-06-17	Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen
FR2662162B1 (fr)	1995-01-20	Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
DE10199003I2 (fr)	2003-09-18
EP0256503A3 (en)	1989-07-19	Pyridinecarboxamide derivatives and their use as fungicide
AU6128590A (en)	1991-02-28	Novel compounds
FI92399B (fi)	1994-07-29	Menetelmä lääkeaineena käyttökelpoisen tiatsolidinonin johdannaisen valmistamiseksi
AU6129890A (en)	1991-02-28	Novel compounds
DE69230958D1 (de)	2000-05-31	Arzneizusammensetzung auf Basis von Dioxabicyclo[3.3.0]octanderivaten
PT81855B (pt)	1987-11-30	Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem
ES2064461T3 (es)	1995-02-01	Derivados de xantina, procedimiento para su preparacion y composicion farmaceutica.
AU3381389A (en)	1989-11-02	Derivative of caffeic acid and pharmaceutical composition containing the same
BR1101136A (pt)	1999-12-07	Derivado da pristinamicina iib, (dietilamino-2 metil-1 etil) sulfinil-26 pristinamicina iib, (dietilamino-2 propil) sulfonil-26 pristinamicina iib, (diisopropilamino-2 etil) sulfonil-26 pristinamicina iib, processo de preparação de novo derivado da pristinamicina iib e composição farmacêutica
KR860008973A (ko)	1986-12-19	2-피롤리돈 유도체
LV10235A (lv)	1994-10-20	Jauni esteri to iegusanas panemiens farmaceitiska kompozicija arstesanas metode
FR2709306B1 (fr)	1995-10-20	Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
IE901314L (en)	1990-10-15	2- substituted-n,n'-di(trimethoxybenzoyl)piperazines
ATE148128T1 (de)	1997-02-15	Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
HU907224D0 (en)	1991-05-28	Process for producing heterocyclic compounds
DK508484D0 (da)	1984-10-25	N-substituerede isoquinolinderivater og farmaceutisk praeparat indeholdende dem
ATE36154T1 (de)	1988-08-15	4-phenylaminopyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
FR2694557B1 (fr)	1994-09-23	Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique.
AU624724B2 (en)	1992-06-18	Pyrrolo(2,1-b)thiazole derivatives
DK480389A (da)	1990-03-31	Antitumor-aktivt derivat af sf2587, fremgangsmaade til det fremstilling og anticancermiddel indeholdende stoffet